Seth Fischer

Mr. Fischer joined the Milestone Pharmaceuticals Board of Directors in March 2023. He brings to the Board nearly 40 years of experience serving in key leadership positions in the pharmaceutical and medical device industry. Mr. Fischer also currently serves on the board of directors of Esperion Therapeutics, Inc., Spectrum Pharmaceuticals, Inc., Marinus Pharmaceuticals, Inc., and Agile Therapeutics, Inc. He is also an advisor to HealthQuest Capital.

Most recently, Mr. Fischer served as the Chief Executive Officer and as a Director of Vivus, Inc., a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health (2013 to 2017). Mr. Fischer began his career in the industry at Johnson & Johnson, where he spent 29 years in various positions of increasing responsibility, most recently as Company Group Chairman, Johnson & Johnson, and Worldwide Franchise Chairman, Cordis Corporation (2008 to 2012), which included responsibility for Cordis and Biosense Webster, and as Company Group Chairman, North America Pharmaceuticals (2004 to 2007), which included responsibility for Ortho‑McNeil Pharmaceuticals, Janssen, McNeil Pediatrics, and Scios. Prior to this position, he served as President of Ortho‑McNeil Pharmaceuticals (2000 to 2004), with his operating responsibilities encompassing the commercialization of products in multiple therapeutic categories including epilepsy, migraine, and products in the analgesic, anti‑infective, cardiovascular, neurologic, psychiatric and women’s health areas.

Mr. Fischer obtained a Bachelor of General Studies from Ohio University and served as a captain in the U.S. Air Force.